Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell Carcinoma
Clinical trial NCT03562507 · TERMINATED
Trial details
- NCT number
- NCT03562507
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-11
- Primary completion
- 2022-10-18
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.